MARKET

SELB

SELB

Selecta Biosci
NASDAQ
1.510
+0.010
+0.67%
After Hours: 1.510 0 0.00% 19:01 09/26 EDT
OPEN
1.470
PREV CLOSE
1.500
HIGH
1.570
LOW
1.465
VOLUME
440.88K
TURNOVER
0
52 WEEK HIGH
4.510
52 WEEK LOW
0.6469
MARKET CAP
230.60M
P/E (TTM)
6.51
1D
5D
1M
3M
1Y
5Y
Selecta Biosciences to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR® platform to develop tolerogenic therapies for autoimmune diseases, enhance gene therapies and...
GlobeNewswire · 09/12 12:00
Selecta Biosciences (NASDAQ:SELB) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Simply Wall St. · 08/30 10:21
This Small-Cap Biotech is a Sneaky Play on Next-Gen Drugs
Selecta Biosciences is one of the most mature companies in an area attracting the attention of industry titans.
TheStreet.com · 08/29 21:08
10 Best One Dollar Stocks To Buy Now
In this article, we discuss the 10 best one dollar stocks to buy now. You can skip our detailed analysis of these stocks and the current market situation, and go directly to 5 Best One Dollar Stocks To Buy Now. When most people think about trading stocks, ...
Insider Monkey · 08/12 13:30
Need To Know: Analysts Are Much More Bullish On Selecta Biosciences, Inc. (NASDAQ:SELB)
Shareholders in Selecta Biosciences, Inc. ( NASDAQ:SELB ) may be thrilled to learn that the analysts have just...
Simply Wall St. · 08/09 14:25
What Kind Of Investors Own Most Of Selecta Biosciences, Inc. (NASDAQ:SELB)?
Every investor in Selecta Biosciences, Inc. ( NASDAQ:SELB ) should be aware of the most powerful shareholder groups...
Simply Wall St. · 08/06 12:25
Allied Healthcare, Progyny top healthcare gainers; Quoin, Helius lead losers' pack
Gainers: Allied Healthcare Products (AHPI) +30%. </b...
Seekingalpha · 08/05 14:02
Selecta stock rises 13% on Q2 beat while revenue doubles
Selecta Biosciences (NASDAQ:SELB) stock rose <font color="gre...
Seekingalpha · 08/04 16:16
More
About SELB
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company leverages its ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. It enables the re-dosing of life-saving gene therapies and restoring self-tolerance in autoimmune diseases. The ImmTOR platform reduces the formation of anti-drug antibodies (ADAs), against biologic drugs and restore self-tolerance to auto-antigens in autoimmune diseases. ImmTOR leverages nanoparticle technology to target rapamycin, an immunomodulatory drug, to antigen presenting cells to generate antigen-specific immune tolerance when combined with the antigen of interest. Its nanoparticles are designed to remain intact after injection into the body and accumulate predominantly in lymph nodes, the spleen, and the liver, where the immune response is coordinated. Its product candidate, SEL-212, which is in Phase III clinical development includes pegadricase, a pegylated uricase enzyme.

Webull offers kinds of Selecta Biosciences Inc stock information, including NASDAQ:SELB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SELB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SELB stock methods without spending real money on the virtual paper trading platform.